Status:
COMPLETED
Accuracy of Infection Biomarkers in the Investigation of Patients With Suspected Acute Pyelonephritis
Lead Sponsor:
University of Southern Denmark
Conditions:
Acute Pyelonephritis
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to investigate the diagnostic and prognostic value of C-reactive protein (CRP), serum procalcitonin (PCT) and soluble urokinase plasminogen activator receptor (suPAR) in the i...
Detailed Description
Acute pyelonephritis (APN) is a severe acute infection in the upper urinary tract, which quite frequently is seen in the emergency department (ED). In our study, we define APN as a urinary tract infec...
Eligibility Criteria
Inclusion
- Suspicion of APN assessed by the receiving physician at the ED
Exclusion
- If the attending physician considers that participation will delay a life-saving treatment or patient needs direct transfer to the intensive care unit.
- Admission within the last 14 days
- Verified COVID-19 disease within 14 days before admission
- Pregnant women
- Severe immunodeficiencies: Primary immunodeficiencies and secondary immunodeficiencies (HIV positive CD4 \<200, Patients receiving immunosuppressive treatment (ATC L04A), Corticosteroid treatment (\>20 mg/day prednisone or equivalent for \>14 days within the last 30 days), Chemotherapy within 30 days)
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
229 Patients enrolled
Trial Details
Trial ID
NCT04686318
Start Date
March 1 2021
End Date
June 1 2022
Last Update
September 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of Southern Jutland
Aabenraa, Denmark